Avistone

Avistone Biotechnology is an innovative biopharmaceutical company at the commercialization stage. Avistone Biotechnology’s research, development, and commercialization efforts are all focused on the field of cancer treatment, committed to providing high-quality innovative drugs for patients worldwide to improve their quality of life. After a decade of dedication, the Avistone team has successfully completed the development of both First-in-class and Best-in-class drugs, which have already been launched in China. In parallel, Avistone has built a highly competitive global pipeline matrix: multiple investigational drugs are in internationally leading clinical trial stages, continuing to address unmet medical needs while laying a solid foundation for its global expansion, showcasing the momentum of transitioning from "Chinese innovation" to "global leadership."